|
DENR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.311760E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.565900E-02 |
| Normal-vs-Stage2 |
1.893710E-02 |
| Normal-vs-Stage3 |
1.522380E-02 |
| Normal-vs-Stage4 |
5.582500E-03 |
| Stage1-vs-Stage2 |
2.624000E-01 |
| Stage1-vs-Stage3 |
2.600800E-01 |
| Stage1-vs-Stage4 |
1.184220E-01 |
| Stage2-vs-Stage3 |
7.638400E-01 |
| Stage2-vs-Stage4 |
9.096000E-01 |
| Stage3-vs-Stage4 |
6.467600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.153930E-02 |
| Normal-vs-AfricanAmerican |
8.296800E-01 |
| Normal-vs-Asian |
2.906600E-01 |
| Caucasian-vs-AfricanAmerican |
8.751800E-02 |
| Caucasian-vs-Asian |
3.778400E-01 |
| AfricanAmerican-vs-Asian |
3.348800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.656440E-02 |
| Normal-vs-Female |
2.176300E-02 |
| Male-vs-Female |
5.912600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.450190E-01 |
| Normal-vs-Age(41-60Yrs) |
1.125790E-02 |
| Normal-vs-Age(61-80Yrs) |
1.102000E-02 |
| Normal-vs-Age(81-100Yrs) |
1.042830E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.131800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.508830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.798600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.162000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.602400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.472400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.213820E-01 |
| Classical-VS-Follicular |
1.440280E-04 |
| Classical-VS-Other |
1.523400E-01 |
| Classical-VS-Normal |
3.723800E-01 |
| Tall-VS-Follicular |
1.995200E-01 |
| Tall-VS-Other |
5.673800E-01 |
| Tall-VS-Normal |
4.310400E-02 |
| Follicular-VS-Other |
9.312800E-01 |
| Follicular-VS-Normal |
1.974040E-04 |
| Other-VS-Normal |
7.934200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.462500E-03 |
| Normal-vs-N1 |
9.366700E-04 |
| N0-vs-N1 |
2.939400E-01 |
|
|
